tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:PYC Stock Latest News

PYC Therapeutics Advances Clinical Trials for PKD Treatment
Company AnnouncementsPYC Therapeutics Advances Clinical Trials for PKD Treatment
9d ago
PYC
PYC Therapeutics Updates Investors in Q3 Webinar
PremiumCompany Announcements
PYC Therapeutics Updates Investors in Q3 Webinar
16d ago
PYC
PYC Therapeutics to Host Investor Webinar on Q3 Progress
PremiumCompany Announcements
PYC Therapeutics to Host Investor Webinar on Q3 Progress
20d ago
PYC
PYC Therapeutics Advances Drug Development Pipeline in Q2 2025
PremiumCompany Announcements
PYC Therapeutics Advances Drug Development Pipeline in Q2 2025
27d ago
PYC
PYC Therapeutics Advances Clinical Trials for PKD Treatment
PremiumCompany Announcements
PYC Therapeutics Advances Clinical Trials for PKD Treatment
1M ago
PYC
PYC Therapeutics Advances Phelan-McDermid Syndrome Program
PremiumCompany AnnouncementsPYC Therapeutics Advances Phelan-McDermid Syndrome Program
2M ago
PYC
PYC Therapeutics Advances VP-001 with FDA Trial Design Approval
Premium
Company Announcements
PYC Therapeutics Advances VP-001 with FDA Trial Design Approval
2M ago
PYC
PYC Therapeutics Advances ADOA Clinical Trial with Dose Escalation Approval
Premium
Company Announcements
PYC Therapeutics Advances ADOA Clinical Trial with Dose Escalation Approval
2M ago
PYC
PYC Therapeutics Updates Investors in Q2 Webinar
PremiumCompany Announcements
PYC Therapeutics Updates Investors in Q2 Webinar
3M ago
PYC
PYC Therapeutics Advances Clinical Trial for PKD Treatment
PremiumCompany Announcements
PYC Therapeutics Advances Clinical Trial for PKD Treatment
3M ago
PYC
PYC Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
PYC Therapeutics Announces Cessation of Securities
3M ago
PYC
PYC Therapeutics Announces Investor Webinar and Updates on Drug Development Progress
PremiumCompany Announcements
PYC Therapeutics Announces Investor Webinar and Updates on Drug Development Progress
3M ago
PYC
PYC Therapeutics Unveils Promising Trial Results for Retinitis Pigmentosa Treatment
PremiumCompany AnnouncementsPYC Therapeutics Unveils Promising Trial Results for Retinitis Pigmentosa Treatment
4M ago
PYC
PYC Therapeutics Announces Change in Substantial Shareholder Interests
Premium
Company Announcements
PYC Therapeutics Announces Change in Substantial Shareholder Interests
4M ago
PYC
PYC Therapeutics Reports Positive Clinical Trial Results for Eye Disease Treatment
Premium
Company Announcements
PYC Therapeutics Reports Positive Clinical Trial Results for Eye Disease Treatment
4M ago
PYC
PYC Therapeutics Advances Towards Commercial Stage with Extended Funding
PremiumCompany Announcements
PYC Therapeutics Advances Towards Commercial Stage with Extended Funding
4M ago
PYC
PYC Therapeutics Announces Quotation of New Securities on ASX
PremiumCompany Announcements
PYC Therapeutics Announces Quotation of New Securities on ASX
4M ago
PYC
PYC Therapeutics Secures $146 Million in Entitlement Offer to Advance RNA Therapies
PremiumCompany Announcements
PYC Therapeutics Secures $146 Million in Entitlement Offer to Advance RNA Therapies
4M ago
PYC
PYC Therapeutics Advances PYC-003 in Polycystic Kidney Disease Trial
PremiumCompany Announcements
PYC Therapeutics Advances PYC-003 in Polycystic Kidney Disease Trial
4M ago
PYC
PYC Therapeutics Secures Majority of Entitlement Offer Amid Underwriter Delays
PremiumCompany AnnouncementsPYC Therapeutics Secures Majority of Entitlement Offer Amid Underwriter Delays
4M ago
PYC
PYC Therapeutics Updates Investors on Business Progress
Premium
Company Announcements
PYC Therapeutics Updates Investors on Business Progress
5M ago
PYC
Buy Rating for PYC Therapeutics: Promising Pipeline and Market Position in Genetic Medicine
Premium
Ratings
Buy Rating for PYC Therapeutics: Promising Pipeline and Market Position in Genetic Medicine
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >